Co-Diagnostics Inc (NASDAQ: CODX) Gets FDA Emergency Authorization For COVID-19 test

Co-Diagnostics Inc (NASDAQ: CODX) is in a rebound after a steep drop in the last two weeks. Today, the company has announced receipt of FDA authorization for its COVID-19 test. The company announced that its Logix Smart ™ COVID-19 test had got EUA (Emergency Use Authorization) by the FDA for testing SARS-COV-2. The company further announced that the test can be used by CLIA certified laboratories to check for the presence of the virus. The company has also announced that the test kits would be available from the company’s Utah facility.

This development comes just a few days after the company released its 2019 full-year results that included some strategic moves that the company was making. Some of the strategic initiatives it had taken include the construction of its CoSara Diagnostics Pvt Ltd, which is a joint venture with Synbiotics aimed at growing sales in India.  The company also announced that it had hit major milestones in the development of its Coprimer technology for use in liquid biopsy applications.

Commenting on this development, CEO Dwight Egan stated that, the company believed that the FDA authorization was a confirmation of the good quality of its COVID-19 tests. He added that this authorization was a major step towards more opportunities to offer its tests to a wider audience. He added that there was consensus among experts that test kits accessibility was a major step towards flattening the COVID-19 curve.  He concluded that the company was aiming to grow the availability of kits affordably all across the world.

From its price action, CODX is in an early uptrend. The stock opened the day at $8.14 and traded between a low of $8.06 and a high of $8.45, before closing the day at $8.20. Volumes in the day stood at 3.35 million.

About Co-Diagnostics Inc

Co-Diagnostics Inc manufactures and sells reagents for medical diagnostics. It is based in Salt Lake City, Utah.

Related Articles

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Fuwei (NASDAQ: FFHL) Plans To Sell Dornier Production Line

Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) recently declared that it will be closing its Dornier line of production as early as possible. Fuwei...

PPG Industries (NYSE: PPG) Announces Accquisition Of Ennis-Flint

PPG Industries, Inc. (NYSE: PPG) is planning to buy Ennis-Flint in a deal valued at nearly $1.15 billion. The decision to acquire Ennis-Flint will...